A new report ranks U.S. states based on factors including livability, health care, and access to recreation. and the top ...
Third quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $51.3 million ---- December 20, 2025 PDUFA goal date ...
Franco-Nevada's record quarterly results benefited from a combination of higher gold prices, strong operations, new acquisitions and the sale of Cobre Panama copper concentrate stockpiles. Our ...
Delivered Q3 2025 revenue of $83 million Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024 Q3 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) ...